8-Amino-2-(1,2,3,4-Tetrazol-5-yl)-4H-Chromen-4-One Hydrochloride

110683-23-3

Chenglian Pharmaceutical is an innovative high-tech pharmaceutic<al enterprise that is market-oriented and realizes industrial development thro→ugh R&D innovation and technology transformation.

key word:

Pharmaceutical innovative

Category:

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and striv™es to build a large health industry finance platform company↕ integrating pharmaceutical, intelligent medical, bio phar maceutical R&D, industrial production and sales$.

The chemical reactions involved in the existing products include Fo>ucault reaction, nitration reaction, sulfonation reaction,§ hydrogenation reaction, fluorination reaction, chlorination reaction, bromination reaction, πdiazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by M'erck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as th§e first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The characteristics of this dδrug are that it can stimulate insulin secretion while reducing hunge&r without causing weight gain. Hypoglycemia and edema will not occur, and ∏it is suitable for diabetic patients with poor blood ↕glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is mar≈ket-oriented and realizes industrial development through R&D innova tion and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most i♥mportant products for the treatment of arthritis. It  is well tolerated and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor ant§agonists. In clinical application, it has good therapeutiαc effect on atopic asthma and other types of bronchial asthma, and the market prospect♣ is huge. In the major category of asthma drugs, leuko¥triene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech phar÷maceutical enterprise that is market-oriented and realizes indust¶rial development through R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the ‍second drug approved by FDA for Alzheimer's disease in the United States. Its tre÷atment reaches the target dose and has low toxic and side effects. I♦t has been widely recognized by our medical community$, and good tolerance is its biggest advantage. In Octobδer 1999, Donepezil was launched in China under the tr☆ade name "Aricept", which is the main chemical drug against Alzheimer's disease. ←At present, CFDA has approved a number of domestic enεterprises to produce donepezil preparations, the main dosa☆ge forms are tablets, capsules, dispersive tablets, oral disintegratin¥g tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Brist±ol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved★ for use in the 27 EU member states. The world's first drug approved✘ to prevent venous thromboembolism (VTE) in adult patients undergoing elective hip or knee rep¥lacement. From June 2019 to June 2020, the annual sales of apixaban products overseas reached about♦ $15.4 billion, with a year-on-year growth of nearly 32%, and the API consumption reacλhed about 23,960 kg, with a year-on-year growth of about 28%. Compared with its® main competitor, Rivaroxaban, the drug's annual over←seas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise th♥at is market-oriented and realizes industrial development through R&D innovation and technology¶ transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On Decemb¥er 29, 2004, it was approved by FDA for the treatment of refract₹ory or relapsed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orient✘ed and realizes industrial development through R&D innovation and✔ technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other •services, E-mail: 2880705932@qq.com
Submit